Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Amazighon May 11, 2021 12:21pm
241 Views
Post# 33174065

R-107: Potentially a wonderful and unique cure

R-107: Potentially a wonderful and unique cureI posted this on another forum and thought this is also applicable here:

I am a scientist and have been studying childhood cancer for many years. I was drawn to Kalytera by its CBD program to prevent and treat GVHD. Now that Claritas has switched to R-107, I am completely sold as an investor and certainly as a scientist. Claritas has already established lines of research towards therapy against SARS-CoV-2 virus and other RNA viruses, e.g. influenza viruses. Diseases such as covid, sepsis, PAH, flu and common cold are diseases that affect millions and even billions of people and Claritas may just have the cure in the form of a pieced together molecule to release nitrogen oxide in a controlled manner. In addition to these diseases, there are several other diseases that can be treated with nitric oxide, in the form of R-107, think of cancer, my field of research. Several cancers can be treated with NO, but the therapy to treat dosed is lacking and I think it might work with R-107.

The fact that several excellent scientists valued by the scientific community have tied their names to Claritas says a lot. I don't know of any scientist, who is valued in the scientific world, who would commit to a company that is not reliable, because honor, prestige, and good name are very important in the scientific world and you don't waste that for any company.

So it is unfortunate that there is so much negativity in the various forums that takes the attention away from the fact that we may have a wonderful and unique cure for many of the diseases that humanity is now suffering from.


<< Previous
Bullboard Posts
Next >>